-
1
-
-
0031822289
-
The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment
-
MUSSELMAN DL, EVANS DL, NEMEROFF CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry (1998) 55:580-592.
-
(1998)
Arch. Gen. Psychiatry
, vol.55
, pp. 580-592
-
-
MUSSELMAN, D.L.1
EVANS, D.L.2
NEMEROFF, C.B.3
-
2
-
-
0141609605
-
Epidemiology of coronary artery disease and depression
-
RUDISCH B, NEMEROFF CB: Epidemiology of coronary artery disease and depression. Biol. Psychiatry (2003) 54:227-240.
-
(2003)
Biol. Psychiatry
, vol.54
, pp. 227-240
-
-
RUDISCH, B.1
NEMEROFF, C.B.2
-
3
-
-
0036174871
-
Depression and heart disease: Evidence of a link, and its therapeutic implications
-
JIANG W, KRISHNAN RR, O'CONNOR CM: Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs (2002) 16:111-127.
-
(2002)
CNS Drugs
, vol.16
, pp. 111-127
-
-
JIANG, W.1
KRISHNAN, R.R.2
O'CONNOR, C.M.3
-
4
-
-
27744535499
-
Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure
-
RUMSFELD JS, JONES PG, WHOOLEY MA et al.: Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am. Heart J. (2005) 150(5)-.961-967.
-
(2005)
Am. Heart J
, vol.150
, Issue.5
, pp. 961-967
-
-
RUMSFELD, J.S.1
JONES, P.G.2
WHOOLEY, M.A.3
-
5
-
-
0035944828
-
Relation between depression after coronary artery bypass surgery and 12-month outcome: A prospective study
-
CONNERNEY I, SHAPIRO PA, McLAUGHLIN JS et al.: Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet (2001) 358:1766-1771.
-
(2001)
Lancet
, vol.358
, pp. 1766-1771
-
-
CONNERNEY, I.1
SHAPIRO, P.A.2
McLAUGHLIN, J.S.3
-
6
-
-
12844278639
-
Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery
-
MALLIK S, KRUMHOLZ HM, LIN ZQ et al.: Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation (2005) 111:271-277.
-
(2005)
Circulation
, vol.111
, pp. 271-277
-
-
MALLIK, S.1
KRUMHOLZ, H.M.2
LIN, Z.Q.3
-
7
-
-
2342433991
-
Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure
-
JOYNT KE, WHELLAN DJ, O'CONNOR CM: Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J. Card. Fail. (2004) 10(3):258-270.
-
(2004)
J. Card. Fail
, vol.10
, Issue.3
, pp. 258-270
-
-
JOYNT, K.E.1
WHELLAN, D.J.2
O'CONNOR, C.M.3
-
8
-
-
0242468515
-
Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure
-
RUMSFELD JS, HAVRANEK EP, MASOUDI F et al.: Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J. Am. Coll. Cardiol. (2003) 42:1811-1817.
-
(2003)
J. Am. Coll. Cardiol
, vol.42
, pp. 1811-1817
-
-
RUMSFELD, J.S.1
HAVRANEK, E.P.2
MASOUDI, F.3
-
9
-
-
0034968156
-
Depressive symptoms and risk of functional decline and death in patients with heart failure
-
VACCARINO V, KASL S, ABRAMSON J, KRUMHOLZ HM: Depressive symptoms and risk of functional decline and death in patients with heart failure. J. Am. Coll. Cardiol. (2001) 38(1):199-205.
-
(2001)
J. Am. Coll. Cardiol
, vol.38
, Issue.1
, pp. 199-205
-
-
VACCARINO, V.1
KASL, S.2
ABRAMSON, J.3
KRUMHOLZ, H.M.4
-
10
-
-
13944254392
-
Depressive symptoms and mortality in patients with congestive heart failure: A six-year follow-up study
-
MURBERG TE, FURZE G: Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study. Med. Sci. Monit. (2004), 10(12):CR643-CR648.
-
(2004)
Med. Sci. Monit
, vol.10
, Issue.12
-
-
MURBERG, T.E.1
FURZE, G.2
-
11
-
-
13944273412
-
Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure
-
SULLIVAN MD, LEVY WC, CRANE BA et al.: Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am. J. Cardiol. (2004) 94:1577-1580.
-
(2004)
Am. J. Cardiol
, vol.94
, pp. 1577-1580
-
-
SULLIVAN, M.D.1
LEVY, W.C.2
CRANE, B.A.3
-
12
-
-
0038690437
-
Depressive symptoms and health-related quality of life: The Heart and Soul Study
-
RUO B, RUMSFELD JS, HLATKY MA et al.: Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 290:215-221.
-
(2003)
JAMA
, vol.290
, pp. 215-221
-
-
RUO, B.1
RUMSFELD, J.S.2
HLATKY, M.A.3
-
13
-
-
17444387493
-
Depression and cardiovascular disease: A reciprocal relationship
-
PLANTE GE: Depression and cardiovascular disease: a reciprocal relationship. Metab. Clin. Exp. (2005) 54(Suppl. 1):45-48.
-
(2005)
Metab. Clin. Exp
, vol.54
, Issue.SUPPL. 1
, pp. 45-48
-
-
PLANTE, G.E.1
-
14
-
-
23844524856
-
Negative impact of depression on outcomes in patients with coronary artery disease: Mechanisms, treatment considerations, and future directions
-
SHIMBO, D, DAVIDSON KW, HAAS DC, FUSTER V, BADIMON JJ: Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions. J. Thromb. Haemost. (2005) 3:897-908.
-
(2005)
J. Thromb. Haemost
, vol.3
, pp. 897-908
-
-
SHIMBO, D.1
DAVIDSON, K.W.2
HAAS, D.C.3
FUSTER, V.4
BADIMON, J.J.5
-
15
-
-
20344370468
-
Depression in chronic heart failure: Novel pathophysiological mechanisms and therapeutic approaches
-
PARISSIS JT, FOUNTOULAKI K, PARASKEVAIDIS I, KREMASTINOS D: Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin. Investig. Drugs (2005) 14(5):567-577.
-
(2005)
Expert Opin. Investig. Drugs
, vol.14
, Issue.5
, pp. 567-577
-
-
PARISSIS, J.T.1
FOUNTOULAKI, K.2
PARASKEVAIDIS, I.3
KREMASTINOS, D.4
-
16
-
-
0027316235
-
The safety of tricyclic antidepressants in cardiac patients: Risk-benefit reconsidered
-
GLASSMAN AH, ROOSE SP, BIGGER JT Jr: The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA (1993) 269:2673-2675.
-
(1993)
JAMA
, vol.269
, pp. 2673-2675
-
-
GLASSMAN, A.H.1
ROOSE, S.P.2
BIGGER Jr, J.T.3
-
17
-
-
0031053807
-
How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?
-
SHELINE YI, FREEDLAND KE, CARNEY RM: How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am. J. Med. (1997) 102:54-59.
-
(1997)
Am. J. Med
, vol.102
, pp. 54-59
-
-
SHELINE, Y.I.1
FREEDLAND, K.E.2
CARNEY, R.M.3
-
18
-
-
0027462948
-
Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability
-
SONG F, FREEMANTLE, N, SHELDON TA et al.: Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br. Med. J. (1993) 306:683-687.
-
(1993)
Br. Med. J
, vol.306
, pp. 683-687
-
-
SONG, F.1
FREEMANTLE, N.2
SHELDON, T.A.3
-
19
-
-
33646846111
-
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: An overview
-
CARRASCO JL, SANDNER C: Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. Int. J. Clin. Pract. (2005) 59(12):1428-1434.
-
(2005)
Int. J. Clin. Pract
, vol.59
, Issue.12
, pp. 1428-1434
-
-
CARRASCO, J.L.1
SANDNER, C.2
-
20
-
-
13244262832
-
Serotonin reuptake inhibitors and cardiovascular disease: A platelet connection
-
MAURER-SPUREJ E: Serotonin reuptake inhibitors and cardiovascular disease: a platelet connection. Cell. Mol. Life Sci. (2005) 6:159-170.
-
(2005)
Cell. Mol. Life Sci
, vol.6
, pp. 159-170
-
-
MAURER-SPUREJ, E.1
-
21
-
-
34447556124
-
-
PFIZER, INC, Zoloft™ (Sertraline) Package Insert. Pfizer, Inc, USA 2002
-
PFIZER, INC.: Zoloft™ (Sertraline) Package Insert. Pfizer, Inc., USA (2002).
-
-
-
-
22
-
-
0344110152
-
Pharmakocinetics of selective serotonin reuptake inhibitors
-
HIEMKE C, HARTTER S: Pharmakocinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther (2000) 85:11-28.
-
(2000)
Pharmacol. Ther
, vol.85
, pp. 11-28
-
-
HIEMKE, C.1
HARTTER, S.2
-
23
-
-
0028099484
-
Pharmacology of antidepressants - characteristics of the ideal drug
-
RICHELSON E: Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clin. Proc. (1994) 69:1069-1081.
-
(1994)
Mayo Clin. Proc
, vol.69
, pp. 1069-1081
-
-
RICHELSON, E.1
-
24
-
-
0031456987
-
Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites
-
OWENS MJ, MORGAN WN, PLOTT SJ, NEMEROFF CB: Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. (1997) 283:1305-1322.
-
(1997)
J. Pharmacol. Exp. Ther
, vol.283
, pp. 1305-1322
-
-
OWENS, M.J.1
MORGAN, W.N.2
PLOTT, S.J.3
NEMEROFF, C.B.4
-
25
-
-
0027464837
-
Clinical pharmacokinetics of selective serotonin reuptake inhibitors
-
VAN HARTEN J: Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin. Pharmacokinet. (1993) 24:203-220.
-
(1993)
Clin. Pharmacokinet
, vol.24
, pp. 203-220
-
-
VAN HARTEN, J.1
-
27
-
-
0031017313
-
Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers
-
RONFELD RA, TREMAINE LM, WILNER KD: Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin. Pharmacokinet. (1997) 32(suppl. 1):22-30.
-
(1997)
Clin. Pharmacokinet
, vol.32
, Issue.SUPPL. 1
, pp. 22-30
-
-
RONFELD, R.A.1
TREMAINE, L.M.2
WILNER, K.D.3
-
28
-
-
0030949753
-
The role of metabolites of antidepressants in the treatment of depression
-
RUDORFER MV, POTTER WZ: The role of metabolites of antidepressants in the treatment of depression. CNS Drugs (1997) 7:273-312.
-
(1997)
CNS Drugs
, vol.7
, pp. 273-312
-
-
RUDORFER, M.V.1
POTTER, W.Z.2
-
29
-
-
0032980470
-
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors
-
443-466
-
DEVANE CL: Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell. Mol. Neurobiol. (1999) 19(4).-443-466.
-
(1999)
Cell. Mol. Neurobiol
, vol.19
, Issue.4
-
-
DEVANE, C.L.1
-
30
-
-
0029051020
-
Sertraline 50 mg daily: The optimal dose in the treatment of depression
-
PRESKORN SH, LANE RM: Sertraline 50 mg daily: the optimal dose in the treatment of depression. Int. J. Clin. Psychopharmacol. (1995) 10:129-141.
-
(1995)
Int. J. Clin. Psychopharmacol
, vol.10
, pp. 129-141
-
-
PRESKORN, S.H.1
LANE, R.M.2
-
31
-
-
0028070312
-
Therapeutic interchange of fluoxetine and sertraline: Experience in the clinical setting
-
STOCK AJ, KOFOED L: Therapeutic interchange of fluoxetine and sertraline: experience in the clinical setting. Am. J. Hosp. Pharm. (1994) 51:2279-2281.
-
(1994)
Am. J. Hosp. Pharm
, vol.51
, pp. 2279-2281
-
-
STOCK, A.J.1
KOFOED, L.2
-
32
-
-
0030463740
-
Pharmacokinetic drug interaction potential of selective serotonin reaptake inhibitors
-
LANE RM: Pharmacokinetic drug interaction potential of selective serotonin reaptake inhibitors. Int. Clin. Pychopharmacol. (1996) 11(Suppl. 5):31-61.
-
(1996)
Int. Clin. Pychopharmacol
, vol.11
, Issue.SUPPL. 5
, pp. 31-61
-
-
LANE, R.M.1
-
33
-
-
0036799221
-
Review of sertraline in post-traumatic stress disorder
-
SCHWARTZ AC, ROTHBAUM BO: Review of sertraline in post-traumatic stress disorder. Expert Opin. Pharmacother (2002) 3(10):1489-1499.
-
(2002)
Expert Opin. Pharmacother
, vol.3
, Issue.10
, pp. 1489-1499
-
-
SCHWARTZ, A.C.1
ROTHBAUM, B.O.2
-
34
-
-
0031974298
-
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline
-
OZDEMIR V, NARANJO CA, HERRMANN N et al.: The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline. J. Clin. Psychopharmacol. (1998) 18(1):55-61.
-
(1998)
J. Clin. Psychopharmacol
, vol.18
, Issue.1
, pp. 55-61
-
-
OZDEMIR, V.1
NARANJO, C.A.2
HERRMANN, N.3
-
36
-
-
0030791275
-
Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers
-
ALDERMAN J, PRESKORN SH, GREENBLATT DJ et al.: Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers. J. Clin. Psychopharmacol. (1997) 17(4):284-291.
-
(1997)
J. Clin. Psychopharmacol
, vol.17
, Issue.4
, pp. 284-291
-
-
ALDERMAN, J.1
PRESKORN, S.H.2
GREENBLATT, D.J.3
-
37
-
-
0030770609
-
The effect of sertraline on the pharmacokinetics of desipramine and imipramine
-
KURTZ DL, BERGSTROM RF, GOLDBERG MJ, CERIMELE BJ: The effect of sertraline on the pharmacokinetics of desipramine and imipramine. Clin. Pharmacol. Ther. (1997) 62(2):145-156.
-
(1997)
Clin. Pharmacol. Ther
, vol.62
, Issue.2
, pp. 145-156
-
-
KURTZ, D.L.1
BERGSTROM, R.F.2
GOLDBERG, M.J.3
CERIMELE, B.J.4
-
38
-
-
0000375514
-
Sertraline, like other SSRIs, is a significant inhibitor of desipramine metabolism in vivo
-
P
-
ZUSSMAN BD, DAVIS CC, FOWLES SE et al.: Sertraline, like other SSRIs, is a significant inhibitor of desipramine metabolism in vivo. Br. J. Clin. Pharmacol. (1995) 39:550P-551P.
-
(1995)
Br. J. Clin. Pharmacol
, vol.39
-
-
ZUSSMAN, B.D.1
DAVIS, C.C.2
FOWLES, S.E.3
-
39
-
-
0030656608
-
Effect of sertraline on plasma nortriptyline levels in depressed elderly
-
SOLAI LK, MULSANT BH, POLLOCK BG et al.: Effect of sertraline on plasma nortriptyline levels in depressed elderly. J. Clin. Psychiatry (1997) 58(10):440-443.
-
(1997)
J. Clin. Psychiatry
, vol.58
, Issue.10
, pp. 440-443
-
-
SOLAI, L.K.1
MULSANT, B.H.2
POLLOCK, B.G.3
-
40
-
-
0028348762
-
Pharmacokinetics of desipramine coadministered with scrtraline or fluoxetine
-
PRESKORN SH, ALDERMAN J, CHUNG M et al.: Pharmacokinetics of desipramine coadministered with scrtraline or fluoxetine. J. Clin. Psychopharmacol. (1994) 14(2):90-98.
-
(1994)
J. Clin. Psychopharmacol
, vol.14
, Issue.2
, pp. 90-98
-
-
PRESKORN, S.H.1
ALDERMAN, J.2
CHUNG, M.3
-
41
-
-
0034864627
-
Review of sertraline and its clinical applications in psychiatric disorders
-
MCRAE AL, BRADY KT. Review of sertraline and its clinical applications in psychiatric disorders. Expert Opin. Pharmacother. (2001) 2(5):883-892.
-
(2001)
Expert Opin. Pharmacother
, vol.2
, Issue.5
, pp. 883-892
-
-
MCRAE, A.L.1
BRADY, K.T.2
-
42
-
-
0029918465
-
Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine
-
RAPEPORT WG, WILLIAMS SA, MUIRHEAD DC et al.: Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J. Clin. Psychiatry (1996) 57(Suppl. 1):20-23.
-
(1996)
J. Clin. Psychiatry
, vol.57
, Issue.SUPPL. 1
, pp. 20-23
-
-
RAPEPORT, W.G.1
WILLIAMS, S.A.2
MUIRHEAD, D.C.3
-
43
-
-
0030938244
-
Interaction of sertraline with clozapine
-
PINNINTI NR, DE LEON J: Interaction of sertraline with clozapine. J. Clin. Psychopharmacol. (1997) 17(2):119-120.
-
(1997)
J. Clin. Psychopharmacol
, vol.17
, Issue.2
, pp. 119-120
-
-
PINNINTI, N.R.1
DE LEON, J.2
-
44
-
-
0029953653
-
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors
-
CENTORRINO F, BALDESSARINI RJ, FRANKENBURG FR et al.: Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am. J. Psychiatry (1996) 153(6):820-822.
-
(1996)
Am. J. Psychiatry
, vol.153
, Issue.6
, pp. 820-822
-
-
CENTORRINO, F.1
BALDESSARINI, R.J.2
FRANKENBURG, F.R.3
-
45
-
-
0034918993
-
Sudden cardiac death with clozapine and sertraline combination
-
HOEHNS JD, FOUTS MM, KELLY MW, TU KB: Sudden cardiac death with clozapine and sertraline combination. Ann. Pharmacother. (2001) 35(7-8):862-866.
-
(2001)
Ann. Pharmacother
, vol.35
, Issue.7-8
, pp. 862-866
-
-
HOEHNS, J.D.1
FOUTS, M.M.2
KELLY, M.W.3
TU, K.B.4
-
46
-
-
0031732560
-
Selective serotonin reuptake inhibitors in affective disorders-I. Basic pharmacology
-
GOODNICK PJ, GOLDSTEIN BJ: Selective serotonin reuptake inhibitors in affective disorders-I. Basic pharmacology. J. Psychopharmacol. (1998) 12(3):S5-S20.
-
(1998)
J. Psychopharmacol
, vol.12
, Issue.3
-
-
GOODNICK, P.J.1
GOLDSTEIN, B.J.2
-
47
-
-
0031970013
-
Lamotrigine toxicity secondary to sertraline
-
KAUFMAN KR, GERNER R: Lamotrigine toxicity secondary to sertraline. Seizure (1998) 7(2):163-165.
-
(1998)
Seizure
, vol.7
, Issue.2
, pp. 163-165
-
-
KAUFMAN, K.R.1
GERNER, R.2
-
48
-
-
0036231396
-
Selective serotonin reuptake inhibitor discontinuation syndrome: A review
-
TAMAM L, OZPOYRAZ N: Selective serotonin reuptake inhibitor discontinuation syndrome: a review. Adv. Ther. (2002) 19(1):17-26.
-
(2002)
Adv. Ther
, vol.19
, Issue.1
, pp. 17-26
-
-
TAMAM, L.1
OZPOYRAZ, N.2
-
49
-
-
0000909213
-
A comparison of symptoms following treatment interruption: Evidence from a randomized double-blind trial with fluoxctine, sertraline, and paroxetine
-
FAVA M, ROSENBAUM JF, HOOG S et al.: A comparison of symptoms following treatment interruption: evidence from a randomized double-blind trial with fluoxctine, sertraline, and paroxetine. Biol. Psychiatry (1998) 43(Suppl. 8):69S.
-
(1998)
Biol. Psychiatry
, vol.43
, Issue.SUPPL. 8
-
-
FAVA, M.1
ROSENBAUM, J.F.2
HOOG, S.3
-
50
-
-
0034167383
-
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo controlled trial
-
MICHELSON D, FAVA M, AMSTERDAM J et al.: Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo controlled trial. Br. J. Psychiatry (2000) 176:363-368.
-
(2000)
Br. J. Psychiatry
, vol.176
, pp. 363-368
-
-
MICHELSON, D.1
FAVA, M.2
AMSTERDAM, J.3
-
51
-
-
0031459202
-
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
-
STAHL MM, LINDQUIST M, PETTERSSON M et al.: Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur. J. Clin. Pharmacol. (1997) 53(3-4):163-169.
-
(1997)
Eur. J. Clin. Pharmacol
, vol.53
, Issue.3-4
, pp. 163-169
-
-
STAHL, M.M.1
LINDQUIST, M.2
PETTERSSON, M.3
-
52
-
-
0030576936
-
Blood coagulation and platelet aggegation in major depression
-
MAES M, VAN DER PLANKEN M, VAN GASTEL A et al.: Blood coagulation and platelet aggegation in major depression. J. Affect. Disord. (1996) 40:35-40.
-
(1996)
J. Affect. Disord
, vol.40
, pp. 35-40
-
-
MAES, M.1
VAN DER PLANKEN, M.2
VAN GASTEL, A.3
-
53
-
-
0033520025
-
Serotonin is associated with coronary artery disease and cardiac events
-
VIKENES K, FARSTAD M, NORDREHAUG JE: Serotonin is associated with coronary artery disease and cardiac events. Circulation (1999) 100:483-489.
-
(1999)
Circulation
, vol.100
, pp. 483-489
-
-
VIKENES, K.1
FARSTAD, M.2
NORDREHAUG, J.E.3
-
54
-
-
0036467938
-
Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes
-
SHIMBO D, CHILD J, DAVIDSON K et al.: Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am. J. Cardiol. (2002) 89:331-333.
-
(2002)
Am. J. Cardiol
, vol.89
, pp. 331-333
-
-
SHIMBO, D.1
CHILD, J.2
DAVIDSON, K.3
-
55
-
-
0028890964
-
Serotonin uptake inhibitors modulate intracellular calcium mobilization in platelets
-
HELMESTE D, TANG S, REIST C et al.: Serotonin uptake inhibitors modulate intracellular calcium mobilization in platelets. Eur. J. Pharmacol. (1995) 288:373-377.
-
(1995)
Eur. J. Pharmacol
, vol.288
, pp. 373-377
-
-
HELMESTE, D.1
TANG, S.2
REIST, C.3
-
56
-
-
0026760806
-
Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients: Relationship to clinical improvement
-
CELADA P, DOLERA M, ALVAREZ E et al.: Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients: relationship to clinical improvement. J. Affect. Disord. (1992) 25:243-249.
-
(1992)
J. Affect. Disord
, vol.25
, pp. 243-249
-
-
CELADA, P.1
DOLERA, M.2
ALVAREZ, E.3
-
57
-
-
0043180436
-
Sertraline Antidepressant Heart Attack Randomized Trial Study Group. Platelet/ endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy
-
SEREBRUANY VL, GLASSMAN AH, MALININ AI et al.: Sertraline Antidepressant Heart Attack Randomized Trial Study Group. Platelet/ endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation (2003) 108:939-944.
-
(2003)
Circulation
, vol.108
, pp. 939-944
-
-
SEREBRUANY, V.L.1
GLASSMAN, A.H.2
MALININ, A.I.3
-
58
-
-
20044370662
-
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression
-
SEREBRUANY VL, SUCKOW RF, COOPER TB et al.: Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am. J. Psychiatry (2005) 162:1165-1170.
-
(2005)
Am. J. Psychiatry
, vol.162
, pp. 1165-1170
-
-
SEREBRUANY, V.L.1
SUCKOW, R.F.2
COOPER, T.B.3
-
59
-
-
0343593736
-
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHART trial): Sertraline Anti-Depressant Heart Attack Trial
-
SHAPIRO PA, LESPERANCE F, FRASURE-SMITH N et al.: An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHART trial): Sertraline Anti-Depressant Heart Attack Trial. Am. Heart J. (1999) 137:1100-1106.
-
(1999)
Am. Heart J
, vol.137
, pp. 1100-1106
-
-
SHAPIRO, P.A.1
LESPERANCE, F.2
FRASURE-SMITH, N.3
-
60
-
-
0037077490
-
Sertraline treatment of major depression in patients with acute MI or unstable angina
-
GLASSMAN AH, O'CONNOR CM, CALIFF RM et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 288:701-709.
-
(2002)
JAMA
, vol.288
, pp. 701-709
-
-
GLASSMAN, A.H.1
O'CONNOR, C.M.2
CALIFF, R.M.3
-
61
-
-
0242488860
-
-
SWENSON JR, O'CONNOR CM, BARTON D et al. AND SERTRALINE ANTIDEPRESSANT HEART ATTACK RANDOMIZED TRIAL (SADHART) GROUP: Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am. J. Cardiol. (2003) 92(11):1271-1276.
-
SWENSON JR, O'CONNOR CM, BARTON D et al. AND SERTRALINE ANTIDEPRESSANT HEART ATTACK RANDOMIZED TRIAL (SADHART) GROUP: Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am. J. Cardiol. (2003) 92(11):1271-1276.
-
-
-
-
62
-
-
0035899867
-
Selective serotonin reuptake inhibitors and myocardial infarction
-
SAUER WH, BERLIN JA, KIMMEL SE: Selective serotonin reuptake inhibitors and myocardial infarction. Circulation (2001) 104(16):1894-1898.
-
(2001)
Circulation
, vol.104
, Issue.16
, pp. 1894-1898
-
-
SAUER, W.H.1
BERLIN, J.A.2
KIMMEL, S.E.3
-
63
-
-
0038507402
-
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial
-
BERKMAN LF, BLUMENTHAL J, BURG M et al.: Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA (2003) 289:3106-3116.
-
(2003)
JAMA
, vol.289
, pp. 3106-3116
-
-
BERKMAN, L.F.1
BLUMENTHAL, J.2
BURG, M.3
-
64
-
-
0034806969
-
Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction
-
McFARLANE A, KAMATH MV, FALLEN EL et al.: Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am. Heart J. (2001) 142:617-623.
-
(2001)
Am. Heart J
, vol.142
, pp. 617-623
-
-
McFARLANE, A.1
KAMATH, M.V.2
FALLEN, E.L.3
-
65
-
-
0041967519
-
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin
-
SEREBRUANY VL, GLASSMAN AH, MALININ AI et al.: Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur. J. Heart Fail. (2003) 5:517-521.
-
(2003)
Eur. J. Heart Fail
, vol.5
, pp. 517-521
-
-
SEREBRUANY, V.L.1
GLASSMAN, A.H.2
MALININ, A.I.3
-
66
-
-
0033621141
-
Mechanisms and models in heart failure: A combinatorial approach
-
MANN DL: Mechanisms and models in heart failure: a combinatorial approach. Circulationa (1999) 100:999-1008.
-
(1999)
Circulationa
, vol.100
, pp. 999-1008
-
-
MANN, D.L.1
-
67
-
-
0028271405
-
Basic mechanisms in congestive heat failure: Recognizing the role of pro-inflammatory cytokines
-
MANN DL, YOUNG JB: Basic mechanisms in congestive heat failure: recognizing the role of pro-inflammatory cytokines. Chest (1994) 105:897-904.
-
(1994)
Chest
, vol.105
, pp. 897-904
-
-
MANN, D.L.1
YOUNG, J.B.2
-
68
-
-
1642463859
-
Inflammatory mediators in chronic heart failure: An overview
-
ANKER SD, VON HAEHLING S: Inflammatory mediators in chronic heart failure: an overview. Heart (2004) 90:464-470.
-
(2004)
Heart
, vol.90
, pp. 464-470
-
-
ANKER, S.D.1
VON HAEHLING, S.2
-
70
-
-
0033282727
-
Major depression and activation of the inflammatory response system
-
MAES M: Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. (1999) 461:25-46.
-
(1999)
Adv. Exp. Med. Biol
, vol.461
, pp. 25-46
-
-
MAES, M.1
-
72
-
-
0029162558
-
Cytokine-to-brain communication: A review and analysis of alternative mechanisms
-
WATKINS LR, MAIER SF, GOEHLER LE: Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. (1995) 57:1011-1026.
-
(1995)
Life Sci
, vol.57
, pp. 1011-1026
-
-
WATKINS, L.R.1
MAIER, S.F.2
GOEHLER, L.E.3
-
73
-
-
0035021538
-
Cytokine-associated emotional and cognitive disturbances in humans
-
REICHENBERG A, YIRMIYA R, SCHOULD A et al.: Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry (2001) 58:445-452.
-
(2001)
Arch. Gen. Psychiatry
, vol.58
, pp. 445-452
-
-
REICHENBERG, A.1
YIRMIYA, R.2
SCHOULD, A.3
-
74
-
-
7944229162
-
-
PARISSISJ, ADAMOPOULOS S, RIGAS A et al.: Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am. J. Cardiol. (2004) 94:1326-1328.
-
PARISSISJ, ADAMOPOULOS S, RIGAS A et al.: Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am. J. Cardiol. (2004) 94:1326-1328.
-
-
-
-
75
-
-
0033057940
-
Negative immunoregulatory effects of antidepressants: Inhibition of IFN-γ and stimulation of interleukin-10 secretion
-
MAES M, SONG C, LI A et al.: Negative immunoregulatory effects of antidepressants: inhibition of IFN-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology (1999) 20:370-379.
-
(1999)
Neuropsychopharmacology
, vol.20
, pp. 370-379
-
-
MAES, M.1
SONG, C.2
LI, A.3
-
76
-
-
0034938909
-
Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis
-
MOHR D, GOODKIN D, ISLAR J, HAUSER S, GENAIN C: Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch. Neurol. (2001) 58:1081-1086.
-
(2001)
Arch. Neurol
, vol.58
, pp. 1081-1086
-
-
MOHR, D.1
GOODKIN, D.2
ISLAR, J.3
HAUSER, S.4
GENAIN, C.5
-
77
-
-
0033945784
-
Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease
-
STEIN PK, CARNEY RM, FREEDLAND KE et al.: Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J. Psychosom. Res. (2000) 48:493-500.
-
(2000)
J. Psychosom. Res
, vol.48
, pp. 493-500
-
-
STEIN, P.K.1
CARNEY, R.M.2
FREEDLAND, K.E.3
-
78
-
-
0035940369
-
Depression, heart rate variability, and acute myocardial infarction
-
CARNEY RM, BLUMENTHAL JA, STEIN PK et al.: Depression, heart rate variability, and acute myocardial infarction. Circulation (2001) 104:2024-2028
-
(2001)
Circulation
, vol.104
, pp. 2024-2028
-
-
CARNEY, R.M.1
BLUMENTHAL, J.A.2
STEIN, P.K.3
-
79
-
-
0942287334
-
Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression
-
GRIPPO AJ, SANTOS CM, JOHNSON RF et al.: Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am. J. Physiol. Heart Circ. Physiol. (2004) 286:H619-H626.
-
(2004)
Am. J. Physiol. Heart Circ. Physiol
, vol.286
-
-
GRIPPO, A.J.1
SANTOS, C.M.2
JOHNSON, R.F.3
-
80
-
-
0032031290
-
Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients
-
PEET M, MURPHY B, SHAY J, HORROBIN D: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry (1998) 43:315-319.
-
(1998)
Biol. Psychiatry
, vol.43
, pp. 315-319
-
-
PEET, M.1
MURPHY, B.2
SHAY, J.3
HORROBIN, D.4
-
81
-
-
0037061915
-
Blood levels of long-chain n-3 fatty acids and the risk of sudden death
-
ALBERT CM, CAMPOS H, STAMPFER MJ et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. (2002) 346:1113-1118.
-
(2002)
N. Engl. J. Med
, vol.346
, pp. 1113-1118
-
-
ALBERT, C.M.1
CAMPOS, H.2
STAMPFER, M.J.3
-
82
-
-
0033015454
-
Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation
-
DUNBAR S, KIMBLE L, JENKINS L et al.: Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress. Anxiety (1999) 9:163-168.
-
(1999)
Depress. Anxiety
, vol.9
, pp. 163-168
-
-
DUNBAR, S.1
KIMBLE, L.2
JENKINS, L.3
-
83
-
-
0034597757
-
QT dispersion in the surface electrocardiogram in ederly patients with major depression
-
NAHSHONI E, AIZENBERG D, STASBERG B et al.: QT dispersion in the surface electrocardiogram in ederly patients with major depression. J. Affect. Disord. (2000) 60:197-200.
-
(2000)
J. Affect. Disord
, vol.60
, pp. 197-200
-
-
NAHSHONI, E.1
AIZENBERG, D.2
STASBERG, B.3
-
84
-
-
0035107201
-
Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects
-
SHORES M, PASCUALLY M, LEWIS N, FLATNESS D, VEITH R: Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology (2001) 26:433-439.
-
(2001)
Psychoneuroendocrinology
, vol.26
, pp. 433-439
-
-
SHORES, M.1
PASCUALLY, M.2
LEWIS, N.3
FLATNESS, D.4
VEITH, R.5
-
85
-
-
16544392759
-
Weight gain during long-term treatment of obsessive - compulsive disorder: A prospective comparison between serotonin reuptake inhibitors
-
MAINA G, ALBERT U, SALVI V, BOGETTO F: Weight gain during long-term treatment of obsessive - compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. J. Clin. Psychiatry (2004) 65(10):1365-1371.
-
(2004)
J. Clin. Psychiatry
, vol.65
, Issue.10
, pp. 1365-1371
-
-
MAINA, G.1
ALBERT, U.2
SALVI, V.3
BOGETTO, F.4
-
86
-
-
33748324652
-
Hyponatremia associated with selective serotonin - reuptake inhibitors in older adults
-
JACOB S, SPINLER SA: Hyponatremia associated with selective serotonin - reuptake inhibitors in older adults. Ann. Pharmacother. (2006) 40(9):1618-1622.
-
(2006)
Ann. Pharmacother
, vol.40
, Issue.9
, pp. 1618-1622
-
-
JACOB, S.1
SPINLER, S.A.2
|